Health Catalyst (HCAT) Q1 Earnings Meet Estimates

Company Performance - Health Catalyst reported quarterly earnings of $0.01 per share, matching the Zacks Consensus Estimate, but down from $0.05 per share a year ago [1] - The company posted revenues of $79.41 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 0.21% and up from $74.72 million year-over-year [2] - Over the last four quarters, Health Catalyst has surpassed consensus revenue estimates three times [2] Stock Movement and Outlook - Health Catalyst shares have declined approximately 42.4% since the beginning of the year, compared to a 4.7% decline in the S&P 500 [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is $0.10 on revenues of $82.87 million, and for the current fiscal year, it is $0.29 on revenues of $334.67 million [7] Industry Context - The Medical Info Systems industry, to which Health Catalyst belongs, is currently ranked in the top 27% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Another company in the same industry, Nyxoah SA, is expected to report a quarterly loss of $0.49 per share, with revenues projected to be $1.59 million, reflecting a 19.7% increase year-over-year [9]